Search Results - "Javela, K."

Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study by Mustonen, P, Lehtonen, K V, Javela, K, Puurunen, M

“…Objectives The long-term prognosis of individuals fulfilling the laboratory criteria, but not clinical criteria, of antiphospholipid syndrome (APS) has not…”
Get full text

Type II antithrombin deficiency caused by a founder mutation Pro73Leu in the Finnish population: clinical picture by Puurunen, M., Salo, P., Engelbarth, S., Javela, K., Perola, M.

“…Summary Background It has been shown that some antithrombin (AT) activity assays do not correctly detect inherited type II AT deficiency, but erroneously…”
Get full text

Evaluation of soluble glycoprotein V as an in vitro quality marker for platelet concentrates: a correlation study between in vitro platelet quality markers and the effect of storage medium by Kiminkinen, L. K. M., Krusius, T., Javela, K. M.

“…Background and objectives Extent of shape change (ESC), hypotonic shock response (HSR), the adhesive glycoprotein CD62P and lactate have been widely used as in…”
Get full text

Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia by Sainio, S., Javela, K., Tuimala, J., Koskinen, S.

“…Summary Objective To study the clinical usefulness of maternal anti‐HPA‐1a antibody levels in predicting severe foetomaternal alloimmune thrombocytopenia…”
Get full text

Interlaboratory workshop on anti‐HPA‐1a alloantibody quantification with the mAb‐specific immobilization of platelet antigen technique by BERTRAND, G., BAKCHOUL, T., JAVELA, K., KILLIE, M. KJAER, KAPLAN, C.

Get full text

Successful liver and lung transplantation in patients with severe IgA deficiency, high anti-IgA concentration and a history of anaphylactic transfusion reaction by Bäckman, S., Javela, K., Koivusalo, A.-M., Isoniemi, H., Halme, M., Hämmäinen, P., Koskinen, S.

Get full text

Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG by JAVELA, K., KEKOMÄKI, R.

“…Summary Recent evidence suggests that platelet‐associated glycoprotein‐specific (GP) antibodies represent true positive autoantibodies and can therefore be…”
Get full text

Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation by Rajantie, J., Javela, K., Joutsi-Korhonen, L., Kekomäki, R.

“…: Objectives : An unselected group of 21 children with chronic thrombocytopenia was investigated to understand the patients’ platelet abnormality better…”
Get full text

Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients by Joutsi-Korhonen, L., Javela, K., Hormila, P., Kekomäki, R.

“…In autoimmune thrombocytopenia, platelet‐associated IgG (PA‐IgG) frequently displays specificity against glycoprotein (GP) IIbIIIa and/or GP IbIX. Because in a…”
Get full text

Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry by Tiller, Heidi, Kamphuis, Marije M, Flodmark, Olof, Papadogiannakis, Nikos, David, Anna L, Sainio, Susanna, Koskinen, Sinikka, Javela, Kaija, Wikman, Agneta Taune, Kekomaki, Riitta, Kanhai, Humphrey H H, Oepkes, Dick, Husebekk, Anne, Westgren, Magnus

“…Objective To characterise pregnancies where the fetus or neonate was diagnosed with fetal and neonatal alloimmune thrombocytopenia (FNAIT) and suffered from…”
Get full text

von Willebrand disease in Finland by Kekomäki, R., Rasi, V., Ebeling, F., Vahtera, E., Javela, K., Koski, T., Myllylä, G., Ikkala, E.

“…The Finnish Red Cross Blood Transfusion Service has served as the national reference laboratory for haemostasis for more than 40 years and remains still the…”
Get full text

Minimal doses of digoxin: a new marker for compliance to medication by Mäenpää, H, Javela, K, Pikkarainen, J, Mälkönen, M, Heinonen, O P, Manninen, V

“…A direct and objective method of measuring compliance to medication is presented. Digoxin is used as a marker in capsules of either gemfibrozil or placebo with…”
Get more information

Soluble glycoprotein V as a quality marker of platelet concentrates stressed by transportation by Javela, Kaija, Eronen, Juha, Sarna, Seppo, Kekomäki, Riitta

“…BACKGROUND: Despite ongoing improvements in storage conditions for platelet concentrates (PCs) for clinical use, leukoreduced platelets (PLTs) undergo subtle…”
Get full text

Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy controls by Sainio, Susanna, Javela, Kaija, Kekomäki, Riitta, Teramo, Kari

“…To extend our knowledge of the kinetics of fetal thrombopoietin (TPO), we studied TPO levels in cord blood plasma and amniotic fluid collected from 15 fetuses…”
Get full text

Evaluation of stored platelets

Get full text

Altered platelet shape change in hereditary gelsolin Asp187Asn-related amyloidosis by Kiuru, S, Javela, K, Somer, H, Kekomäki, R

“…Hereditary gelsolin-related amyloidosis (AGel amyloidosis) is a systemic disorder caused by a G654A or G654T mutation in the gene coding for gelsolin, an…”
Get more information

Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients: GP V-specific platelet-associated IgG by Joutsi-Korhonen, L., Javela, K., Hormila, P., Kekomäki, R.

Get full text

Genetic polymorphism H131R of Fcgamma receptor type IIA (FcgammaRIIA) in a healthy Finnish population and in patients with or without platelet-associated IgG by Joutsi, L, Javela, K, Partanen, J, Kekomäki, R

“…Patients (n=113) with histories of thrombocytopenia and with different profiles for platelet-associated IgG (PA-IgG) were subdivided according to the genetic…”
Get full text

Genetic polymorphism H131R of Fcγ receptor type IIA (FcγRIIA) in a healthy Finnish population and in patients with or without platelet-associated IgG by Joutsi, Lotta, Javela, Kaija, Partanen, Jukka, Kekomäki, Riitta

“…: Patients (n = 113) with histories of thrombocytopenia and with different profiles for platelet‐associated IgG (PA‐IgG) were subdivided according to the…”
Get full text

Variant Bernard-Soulier syndrome due to homozygous Asn45Ser mutation in the platelet glycoprotein (GP) IX in seven patients of five unrelated Finnish families by Koskela, Satu, Javela, Kaija, Jouppila, Jussi, Juvonen, Eeva, Nyblom, Olle, Partanen, Jukka, Kekomäki, Riitta

“…:  Bernard‐Soulier syndrome (BSS), a rare bleeding disorder with macrothrombocytopenia, is caused by a defect of the platelet glycoprotein (GP) Ib/IX/V…”
Get full text